Impact of Baseline Disease Duration on Ozanimod Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 True North Study

Category Primary study
JournalAmerican Journal of Gastroenterology
Year 2024
This article has no abstract
Epistemonikos ID: 82831713c035836795c3732683cfe007803aa0d6
First added on: Feb 19, 2025